Prognostic significance of miR-215 in colon cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA-215 (miR-215) targets key genes like thymidylate synthase (TS) and denticleless protein homolog (DTL) in colon cancer.
• miR-215 acts as a tumor suppressor by upregulating p53 and p21, but paradoxically confers chemoresistance at high levels by inducing cell cycle arrest.
• The clinical significance of miR-215 as a prognostic biomarker in colon cancer requires further investigation.

Purpose of the Study:

• To investigate the clinical significance of miR-215 as a prognostic biomarker in colon cancer patients.
• To analyze the correlation between miR-215 expression levels and patient survival outcomes.
• To examine the expression of miR-215 and its target DTL in colon tumor tissues.

Main Methods:

• RNA extraction from 34 paired normal and colon tumor specimens (stage II and III).
• Quantification of miR-215 and miR-192 levels using quantitative real-time polymerase chain reaction (qRT-PCR).
• Assessment of DTL mRNA and protein expression via qRT-PCR and immunohistochemistry.

Main Results:

• miR-215 and miR-192 expression were significantly decreased in colon tumors compared to normal tissues.
• DTL was over-expressed in tumors and inversely correlated with miR-215, confirming in vivo relevance.
• High miR-215 expression was associated with poor overall patient survival (HR=3.516, P=0.025).
• Elevated DTL protein expression was observed in colon cancer tissues but not in normal tissues.

Conclusions:

• miR-215 demonstrates potential as a prognostic biomarker for stage II and III colon cancer.
• The inverse correlation between miR-215 and DTL highlights a key regulatory mechanism in colon cancer.
• Further research into miR-215's role could lead to improved diagnostic and therapeutic strategies.